Hematology Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Will KRD Replace Stem Cell Transplant?
Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope considers w... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

The Future of Isatuximab
Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope discusses t... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Outcomes from the CASSIOPEIA Trial
Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope provides ou... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Outcomes of ECOG Trial in SMM
Amrita Krishnan, MD, Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope explains ab... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Next Phase of HCC Management and Research
Richard S. Finn, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California explains the next phase of hepatocellular carcinoma (HCC) man... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

The Next Steps if an HCC Patient Fails 1st Line Therapy
Richard S. Finn, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California elaborates on the next steps for an HCC patient if they fail ... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role of I-O in the Management of HCC
Richard S. Finn MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California offers his opinion on the role of immuno-oncology (I-O) in the... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

KEYNOTE-240 in 1st Line HCC Outcome
Richard S. Finn, MD, Assistant Professor of Medicine, Division of Hematology/Oncology, Geffen School of Medicine, University of California explains the outcomes of hepatocellular carcinoma (HCC) in KE... Author: obr Added: 06/27/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2019 Category: Cancer & Oncology Source Type: podcasts

Clinical insights for hematological malignancies from an artificial intelligence decision-support tool.
Dr. Mehool Patel dicusses how artificial intelligence makes an impact on decisions for both clinicians and patients alike. Background: Next generation sequencing (NGS) in hematological tumors is i... Author: Annual-Meeting Added: 06/07/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2019 Category: Cancer & Oncology Source Type: podcasts

R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Earn CME: <a target='_blank' href='https://naccme.com/program/7330'>https://naccme.com/program/...</a> In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New Yor... Author: imedex Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

CLL: Sequencing Monotherapy vs. Combination Therapy
Earn CME: <a target='_blank' href='https://naccme.com/program/7330'>https://naccme.com/program/...</a> In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New Yor... Author: imedex Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Novel Treatment Options in CLL
Earn CME: <a target='_blank' href='https://naccme.com/program/7330'>https://naccme.com/program/...</a> In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New Yor... Author: imedex Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Myeloma Debate: Is MRD Ready for Prime Time? - No
Earn CME: <a target='_blank' href='https://naccme.com/program/7329'>https://naccme.com/program/...</a> In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic... Author: imedex Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

Myeloma Debate: Is MRD Ready for Prime Time? - Yes
Earn CME: <a target='_blank' href='https://naccme.com/program/7329'>https://naccme.com/program/...</a> In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic... Author: imedex Added: 06/04/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2019 Category: Cancer & Oncology Source Type: podcasts

SLCVL Raez 14 Current Standards Leading Options for First-line Treatment of EGFR Mutation NSCLC
GRACE - Global Resource for Advancing Cancer Education Published on Feb 14, 2017 Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Cl... Author: cancergrace Added: 05/28/2019 (Source: Oncology Tube)
Source: Oncology Tube - May 28, 2019 Category: Cancer & Oncology Source Type: podcasts